Filing Details
- Accession Number:
- 0001562180-16-001386
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-01-22 16:25:12
- Reporting Period:
- 2016-01-20
- Filing Date:
- 2016-01-22
- Accepted Time:
- 2016-01-22 16:25:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1271214 | Intersect Ent Inc. | XENT | Surgical & Medical Instruments & Apparatus (3841) | 200280837 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1614649 | E Richard Kaufman | C/O Intersect Ent, Inc. 1555 Adams Drive Menlo Park CA 94025 | Sr Vp& Chief Operating Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2016-01-20 | 3,603 | $17.99 | 212,586 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-01-21 | 3,603 | $17.87 | 208,983 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2015.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.94 to $18.02, inclusive. The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.74 to $18.20, inclusive. The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
Billionaire Hedge Funds
